1 Melanocortin Receptor 4 Market Overview 1.1 Product Overview and Scope of Melanocortin Receptor 4 1.2 Melanocortin Receptor 4 Segment by Type 1.2.1 Global Melanocortin Receptor 4 Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Bremelanotide 1.2.3 Corticotropin 1.2.4 Cosyntropin 1.2.5 Others 1.3 Melanocortin Receptor 4 Segment by Application 1.3.1 Melanocortin Receptor 4 Sales Comparison by Application: (2021-2027) 1.3.2 Metabolic Disorder 1.3.3 Women's Health 1.3.4 Genito Urinary System 1.3.5 Infection Disease 1.3.6 Others 1.4 Global Melanocortin Receptor 4 Market Size Estimates and Forecasts 1.4.1 Global Melanocortin Receptor 4 Revenue 2016-2027 1.4.2 Global Melanocortin Receptor 4 Sales 2016-2027 1.4.3 Melanocortin Receptor 4 Market Size by Region: 2016 Versus 2021 Versus 2027 2 Melanocortin Receptor 4 Market Competition by Manufacturers 2.1 Global Melanocortin Receptor 4 Sales Market Share by Manufacturers (2016-2021) 2.2 Global Melanocortin Receptor 4 Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Melanocortin Receptor 4 Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Melanocortin Receptor 4 Manufacturing Sites, Area Served, Product Type 2.5 Melanocortin Receptor 4 Market Competitive Situation and Trends 2.5.1 Melanocortin Receptor 4 Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Melanocortin Receptor 4 Players Market Share by Revenue 2.5.3 Global Melanocortin Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Melanocortin Receptor 4 Retrospective Market Scenario by Region 3.1 Global Melanocortin Receptor 4 Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Melanocortin Receptor 4 Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Melanocortin Receptor 4 Market Facts & Figures by Country 3.3.1 North America Melanocortin Receptor 4 Sales by Country 3.3.2 North America Melanocortin Receptor 4 Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Melanocortin Receptor 4 Market Facts & Figures by Country 3.4.1 Europe Melanocortin Receptor 4 Sales by Country 3.4.2 Europe Melanocortin Receptor 4 Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Melanocortin Receptor 4 Market Facts & Figures by Region 3.5.1 Asia Pacific Melanocortin Receptor 4 Sales by Region 3.5.2 Asia Pacific Melanocortin Receptor 4 Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Melanocortin Receptor 4 Market Facts & Figures by Country 3.6.1 Latin America Melanocortin Receptor 4 Sales by Country 3.6.2 Latin America Melanocortin Receptor 4 Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Melanocortin Receptor 4 Market Facts & Figures by Country 3.7.1 Middle East and Africa Melanocortin Receptor 4 Sales by Country 3.7.2 Middle East and Africa Melanocortin Receptor 4 Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Melanocortin Receptor 4 Historic Market Analysis by Type 4.1 Global Melanocortin Receptor 4 Sales Market Share by Type (2016-2021) 4.2 Global Melanocortin Receptor 4 Revenue Market Share by Type (2016-2021) 4.3 Global Melanocortin Receptor 4 Price by Type (2016-2021) 5 Global Melanocortin Receptor 4 Historic Market Analysis by Application 5.1 Global Melanocortin Receptor 4 Sales Market Share by Application (2016-2021) 5.2 Global Melanocortin Receptor 4 Revenue Market Share by Application (2016-2021) 5.3 Global Melanocortin Receptor 4 Price by Application (2016-2021) 6 Key Companies Profiled 6.1 AstraZeneca Plc 6.1.1 AstraZeneca Plc Corporation Information 6.1.2 AstraZeneca Plc Description and Business Overview 6.1.3 AstraZeneca Plc Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2016-2021) 6.1.4 AstraZeneca Plc Product Portfolio 6.1.5 AstraZeneca Plc Recent Developments/Updates 6.2 Mallinckrodt Plc 6.2.1 Mallinckrodt Plc Corporation Information 6.2.2 Mallinckrodt Plc Description and Business Overview 6.2.3 Mallinckrodt Plc Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Mallinckrodt Plc Product Portfolio 6.2.5 Mallinckrodt Plc Recent Developments/Updates 6.3 Obexia AG 6.3.1 Obexia AG Corporation Information 6.3.2 Obexia AG Description and Business Overview 6.3.3 Obexia AG Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Obexia AG Product Portfolio 6.3.5 Obexia AG Recent Developments/Updates 6.4 Palatin Technologies, Inc. 6.4.1 Palatin Technologies, Inc. Corporation Information 6.4.2 Palatin Technologies, Inc. Description and Business Overview 6.4.3 Palatin Technologies, Inc. Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Palatin Technologies, Inc. Product Portfolio 6.4.5 Palatin Technologies, Inc. Recent Developments/Updates 6.5 Pfizer Inc. 6.5.1 Pfizer Inc. Corporation Information 6.5.2 Pfizer Inc. Description and Business Overview 6.5.3 Pfizer Inc. Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Pfizer Inc. Product Portfolio 6.5.5 Pfizer Inc. Recent Developments/Updates 6.6 Retrophin Inc. 6.6.1 Retrophin Inc. Corporation Information 6.6.2 Retrophin Inc. Description and Business Overview 6.6.3 Retrophin Inc. Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Retrophin Inc. Product Portfolio 6.6.5 Retrophin Inc. Recent Developments/Updates 6.7 Rhythm Pharmaceuticals, Inc. 6.6.1 Rhythm Pharmaceuticals, Inc. Corporation Information 6.6.2 Rhythm Pharmaceuticals, Inc. Description and Business Overview 6.6.3 Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Rhythm Pharmaceuticals, Inc. Product Portfolio 6.7.5 Rhythm Pharmaceuticals, Inc. Recent Developments/Updates 7 Melanocortin Receptor 4 Manufacturing Cost Analysis 7.1 Melanocortin Receptor 4 Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Melanocortin Receptor 4 7.4 Melanocortin Receptor 4 Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Melanocortin Receptor 4 Distributors List 8.3 Melanocortin Receptor 4 Customers 9 Melanocortin Receptor 4 Market Dynamics 9.1 Melanocortin Receptor 4 Industry Trends 9.2 Melanocortin Receptor 4 Growth Drivers 9.3 Melanocortin Receptor 4 Market Challenges 9.4 Melanocortin Receptor 4 Market Restraints 10 Global Market Forecast 10.1 Melanocortin Receptor 4 Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Melanocortin Receptor 4 by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Melanocortin Receptor 4 by Type (2022-2027) 10.2 Melanocortin Receptor 4 Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Melanocortin Receptor 4 by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Melanocortin Receptor 4 by Application (2022-2027) 10.3 Melanocortin Receptor 4 Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Melanocortin Receptor 4 by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Melanocortin Receptor 4 by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Melanocortin Receptor 4 Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Melanocortin Receptor 4 Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global Melanocortin Receptor 4 Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Melanocortin Receptor 4 Covered in This Study Table 5. Global Melanocortin Receptor 4 Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global Melanocortin Receptor 4 Sales Share by Manufacturers (2016-2021) Table 7. Global Melanocortin Receptor 4 Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Melanocortin Receptor 4 Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Melanocortin Receptor 4 Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Melanocortin Receptor 4 Manufacturing Sites and Area Served Table 11. Manufacturers Melanocortin Receptor 4 Product Type Table 12. Global Melanocortin Receptor 4 Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Melanocortin Receptor 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanocortin Receptor 4 as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Melanocortin Receptor 4 Sales by Region (2016-2021) & (K Pcs) Table 16. Global Melanocortin Receptor 4 Sales Market Share by Region (2016-2021) Table 17. Global Melanocortin Receptor 4 Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Melanocortin Receptor 4 Sales by Country (2016-2021) & (K Pcs) Table 19. North America Melanocortin Receptor 4 Sales Market Share by Country (2016-2021) Table 20. North America Melanocortin Receptor 4 Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Melanocortin Receptor 4 Revenue Market Share by Country (2016-2021) Table 22. Europe Melanocortin Receptor 4 Sales by Country (2016-2021) & (K Pcs) Table 23. Europe Melanocortin Receptor 4 Sales Market Share by Country (2016-2021) Table 24. Europe Melanocortin Receptor 4 Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Melanocortin Receptor 4 Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Melanocortin Receptor 4 Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific Melanocortin Receptor 4 Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Melanocortin Receptor 4 Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Melanocortin Receptor 4 Revenue Market Share by Region (2016-2021) Table 30. Latin America Melanocortin Receptor 4 Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America Melanocortin Receptor 4 Sales Market Share by Country (2016-2021) Table 32. Latin America Melanocortin Receptor 4 Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Melanocortin Receptor 4 Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Melanocortin Receptor 4 Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa Melanocortin Receptor 4 Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Melanocortin Receptor 4 Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Melanocortin Receptor 4 Revenue Market Share by Country (2016-2021) Table 38. Global Melanocortin Receptor 4 Sales (K Pcs) by Type (2016-2021) Table 39. Global Melanocortin Receptor 4 Sales Market Share by Type (2016-2021) Table 40. Global Melanocortin Receptor 4 Revenue (Million US$) by Type (2016-2021) Table 41. Global Melanocortin Receptor 4 Revenue Share by Type (2016-2021) Table 42. Global Melanocortin Receptor 4 Price (USD/Pcs) by Type (2016-2021) Table 43. Global Melanocortin Receptor 4 Sales (K Pcs) by Application (2016-2021) Table 44. Global Melanocortin Receptor 4 Sales Market Share by Application (2016-2021) Table 45. Global Melanocortin Receptor 4 Revenue (Million US$) by Application (2016-2021) Table 46. Global Melanocortin Receptor 4 Revenue Share by Application (2016-2021) Table 47. Global Melanocortin Receptor 4 Price (USD/Pcs) by Application (2016-2021) Table 48. AstraZeneca Plc Corporation Information Table 49. AstraZeneca Plc Description and Business Overview Table 50. AstraZeneca Plc Melanocortin Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. AstraZeneca Plc Melanocortin Receptor 4 Product Table 52. AstraZeneca Plc Recent Developments/Updates Table 53. Mallinckrodt Plc Corporation Information Table 54. Mallinckrodt Plc Description and Business Overview Table 55. Mallinckrodt Plc Melanocortin Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Mallinckrodt Plc Melanocortin Receptor 4 Product Table 57. Mallinckrodt Plc Recent Developments/Updates Table 58. Obexia AG Corporation Information Table 59. Obexia AG Description and Business Overview Table 60. Obexia AG Melanocortin Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Obexia AG Melanocortin Receptor 4 Product Table 62. Obexia AG Recent Developments/Updates Table 63. Palatin Technologies, Inc. Corporation Information Table 64. Palatin Technologies, Inc. Description and Business Overview Table 65. Palatin Technologies, Inc. Melanocortin Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. Palatin Technologies, Inc. Melanocortin Receptor 4 Product Table 67. Palatin Technologies, Inc. Recent Developments/Updates Table 68. Pfizer Inc. Corporation Information Table 69. Pfizer Inc. Description and Business Overview Table 70. Pfizer Inc. Melanocortin Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. Pfizer Inc. Melanocortin Receptor 4 Product Table 72. Pfizer Inc. Recent Developments/Updates Table 73. Retrophin Inc. Corporation Information Table 74. Retrophin Inc. Description and Business Overview Table 75. Retrophin Inc. Melanocortin Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 76. Retrophin Inc. Melanocortin Receptor 4 Product Table 77. Retrophin Inc. Recent Developments/Updates Table 78. Rhythm Pharmaceuticals, Inc. Corporation Information Table 79. Rhythm Pharmaceuticals, Inc. Description and Business Overview Table 80. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 81. Rhythm Pharmaceuticals, Inc. Melanocortin Receptor 4 Product Table 82. Rhythm Pharmaceuticals, Inc. Recent Developments/Updates Table 83. Production Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Melanocortin Receptor 4 Distributors List Table 86. Melanocortin Receptor 4 Customers List Table 87. Melanocortin Receptor 4 Market Trends Table 88. Melanocortin Receptor 4 Growth Drivers Table 89. Melanocortin Receptor 4 Market Restraints Table 90. Global Melanocortin Receptor 4 Sales Forecast by Type (2022-2027) & (K Pcs) Table 91. Global Melanocortin Receptor 4 Sales Market Share Forecast by Type (2022-2027) Table 92. Global Melanocortin Receptor 4 Revenue Forecast by Type (2022-2027) & (US$ Million) Table 93. Global Melanocortin Receptor 4 Revenue Market Share Forecast by Type (2022-2027) Table 94. Global Melanocortin Receptor 4 Sales Forecast by Application (2022-2027) & (K Pcs) Table 95. Global Melanocortin Receptor 4 Sales Market Share Forecast by Application (2022-2027) Table 96. Global Melanocortin Receptor 4 Revenue Forecast by Application (2022-2027) & (US$ Million) Table 97. Global Melanocortin Receptor 4 Revenue Market Share Forecast by Application (2022-2027) Table 98. Global Melanocortin Receptor 4 Sales Forecast by Region (2022-2027) & (K Pcs) Table 99. Global Melanocortin Receptor 4 Sales Market Share Forecast by Region (2022-2027) Table 100. Global Melanocortin Receptor 4 Revenue Forecast by Region (2022-2027) & (US$ Million) Table 101. Global Melanocortin Receptor 4 Revenue Market Share Forecast by Region (2022-2027) Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Melanocortin Receptor 4 Figure 2. Global Melanocortin Receptor 4 Market Share by Type in 2020 & 2027 Figure 3. Bremelanotide Product Picture Figure 4. Corticotropin Product Picture Figure 5. Cosyntropin Product Picture Figure 6. Others Product Picture Figure 7. Global Melanocortin Receptor 4 Market Share by Application in 2020 & 2027 Figure 8. Metabolic Disorder Figure 9. Women's Health Figure 10. Genito Urinary System Figure 11. Infection Disease Figure 12. Others Figure 13. Global Melanocortin Receptor 4 Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Melanocortin Receptor 4 Market Size 2016-2027 (US$ Million) Figure 15. Global Melanocortin Receptor 4 Sales 2016-2027 (K Pcs) Figure 16. Global Melanocortin Receptor 4 Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 17. Melanocortin Receptor 4 Sales Share by Manufacturers in 2020 Figure 18. Global Melanocortin Receptor 4 Revenue Share by Manufacturers in 2020 Figure 19. The Global 5 and 10 Largest Melanocortin Receptor 4 Players: Market Share by Revenue in 2020 Figure 20. Melanocortin Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 21. Global Melanocortin Receptor 4 Sales Market Share by Region (2016-2021) Figure 22. Global Melanocortin Receptor 4 Sales Market Share by Region in 2020 Figure 23. Global Melanocortin Receptor 4 Revenue Market Share by Region (2016-2021) Figure 24. Global Melanocortin Receptor 4 Revenue Market Share by Region in 2020 Figure 25. U.S. Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Canada Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Germany Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. France Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. U.K. Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Italy Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Russia Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. China Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Japan Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. South Korea Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. India Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Australia Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Taiwan Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Indonesia Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Thailand Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Malaysia Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Philippines Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Vietnam Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Mexico Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Brazil Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Argentina Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Turkey Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Saudi Arabia Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. U.A.E Melanocortin Receptor 4 Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Sales Market Share of Melanocortin Receptor 4 by Type (2016-2021) Figure 50. Sales Market Share of Melanocortin Receptor 4 by Application (2016-2021) Figure 51. Sales Market Share of Melanocortin Receptor 4 by Application in 2020 Figure 52. Revenue Share of Melanocortin Receptor 4 by Application (2016-2021) Figure 53. Revenue Share of Melanocortin Receptor 4 by Application in 2020 Figure 54. Manufacturing Cost Structure of Melanocortin Receptor 4 Figure 55. Manufacturing Process Analysis of Melanocortin Receptor 4 Figure 56. Melanocortin Receptor 4 Industrial Chain Analysis Figure 57. Channels of Distribution Figure 58. Distributors Profiles Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

AstraZeneca Plc Mallinckrodt Plc Obexia AG Palatin Technologies, Inc. Pfizer Inc. Retrophin Inc. Rhythm Pharmaceuticals, Inc.